I
IMM
IMMUTEP LTD
0.33
0.01+1.56%Closed16:10 01/22 AEDT
OPEN/PREV CLOSE0.320/0.320
TODAY RANGE0.315-0.330
VOL2.30M
MARKET CAP476.71M
52 WEEK RANGE0.230-0.485
AVG VOL (3M)3.98M
% TURNOVER0.04%
TURNOVER742.38K
P/E (TTM)-9.3040
% RANGE4.69%
EPS(TTM)-0.0352
P/E(FORWARD)-7.2456
P/B2.533
BVPS0.129
DIVIDEND--
P/S3,275.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP462.21M
SHARES OUTSTANDING1.46B
NEXT EARNINGS02/25-03/02
FREE FLOAT1.41B
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
ASX·01/05 21:57
Patient Enrolment Completed for INSIGHT-003
ASX·12/25/2024 18:01
Esg Summary Report
ASX·12/17/2024 06:24
Notification of cessation of securities - IMM
ASX·12/16/2024 21:22
Immutep announces initial safety data from IMP761 phase 1
ASX·12/15/2024 21:27
Publication Detailing How Human LAG-3 Binds to MHC Class II
ASX·12/13/2024 01:11
Application for quotation of securities - IMM
The Motley Fool·12/12/2024 00:38
ASX 300 healthcare stock lifts off on promising new results
ASX·12/11/2024 22:03
Immutep Reports Promising New Data in Head and Neck Cancer
Dow Jones·12/10/2024 06:07
*Immutep Target Price Raised 82% to A$2.00/Share by Jefferies>IMM.AU
ASX·12/10/2024 03:51
Change of Director's Interest Notice - L Boyce
ASX·12/10/2024 03:49
Change of Director's Interest Notice - R Howard
ASX·12/10/2024 03:47
Change of Director's Interest Notice - F Triebel
ASX·12/10/2024 03:45
Change of Director's Interest Notice - M Voigt
ASX·12/09/2024 22:45
Initiation of TACTI-004 phase 3 trial in 1st line NSCLC
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others